Invitation to the presentation of ALK’s first six months (Q2) 2025 results on Thursday, 21 August 2025

How did the company's operating margins and EBITDA change versus the prior period? What were the primary drivers behind any revenue or earnings surprise (e.g., product launches, cost reductions, regulatory approvals)? How is the company's cash flow, capex spending, and free cash flow for the first six months? What is the current guidance on capital allocation—dividends, share buybacks, or debt reduction? How does ALK's performance compare with its main competitors and the broader sector in the same quarter? What are the key macro‑economic or regulatory factors that could affect ALK’s performance in the remainder of 2025? Are there any changes in management, strategy, or business outlook disclosed in the presentation? What is the market's expected reaction to the results, and how might the stock price move in the short term? What technical indicators or price patterns could be impacted by the earnings release? What were ALK's revenue and profit figures for the first half of 2025, and how do they compare to the same period last year? Did ALK meet, exceed, or miss analyst consensus expectations for earnings per share and revenue? What guidance did ALK provide for the full-year 2025 outlook, including revenue, EPS, and margins?